Yuki Noguchi
Yuki Noguchi is a correspondent on the Science Desk based out of NPR's headquarters in Washington, D.C. She started covering consumer health in the midst of the pandemic, reporting on everything from vaccination and racial inequities in access to health, to cancer care, obesity and mental health.
Since joining NPR in 2008, Noguchi has also covered a range of business and economic news, with a special focus on the workplace — anything that affects how and why we work. In recent years, she has covered the rise of the contract workforce, the #MeToo movement, the Great Recession and the subprime housing crisis. In 2011, she covered the earthquake and tsunami in her parents' native Japan. Her coverage of the impact of opioids on workers and their families won a 2019 Gracie Award and received First Place and Best In Show in the radio category from the National Headliner Awards. She also loves featuring offbeat topics, and has eaten insects in service of journalism.
Noguchi started her career as a reporter, then an editor, for The Washington Post.
Noguchi grew up in St. Louis, inflicts her cooking on her two boys and has a degree in history from Yale.
-
Private Medicare plans that pay for prescription drugs can now cover obesity medicine Wegovy, if it's prescribed to reduce the risk of heart attacks and strokes in people at high risk.
-
This change follows the recent FDA approval of the weight-loss drug for preventing heart attack and stroke in people with overweight or obesity. -
The alternatives have a similar taste, packaging and marketing. Anti-smoking activists say this is a way to get around state and federal bans. -
Black smokers make up menthol tobacco's largest market, and have the highest rates of lung cancer. But the fight over banning menthol is a complex and divisive issue in the Black community. -
New York City joined other localities this week in pledging to buy up and forgive residents' unpaid medical bills. The trend started in Cook County, Ill., and is spreading around the country. -
Weight-loss medications tamp down hunger — often dramatically — causing some people to lose the pleasure of communing over food at a festive family meal. -
Obesity medications like Wegovy that tamp down hunger mean some people are navigating life and the holidays without an appetite. This changes social interactions and a traditional source of comfort.
-
A new survey finds more people are surviving lung cancer and racial disparities are shrinking. But unless it's caught early, lung cancer still has a low survival rate. -
Americans depend on generic drugs for 90% of prescriptions. But shortages have become a chronic problem. Generic drug manufacturing has become a race to get to the lowest price.
-
Eli Lilly said the obesity medicine, which helped adults in clinical studies lose about 20% of their body weight, will be available in the U.S. by the end of the year. The list price will be $1,060. -
Humans instinctually forge loyalties to groups to survive. Being aware of these impulses can help us deescalate arguments and find common ground. Some notable leaders in history show us how it's done. -
New guidelines say more current and former smokers should get screened on a yearly basis. New treatments for lung cancer make early detection of the lethal disease more important.
